Bioptimus
PrivateLast Round
Series A
Jan 14, 2025
Total Funding Raised
$117M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Bioptimus is a biotechnology and artificial intelligence company that develops a universal AI foundation model to enhance scientific research and drive biotechnological innovation by transforming multiscale biological data into actionable insights.
Sector
AI, Data & Cloud Infrastructure
Verticals
Medical AI, Drug Discovery, ML Platforms, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Data as a Service
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bioptimus Comparables
Compare Bioptimus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EvolutionaryScale | 82% | |
| Tahoe Therapeutics | 81% | |
| Aignostics | 79% |
Bioptimus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 14, 2025 | ||||
| Series A | Jan 14, 2025 | ||||
| Seed | Feb 20, 2024 |
Key People
Founding team and executive leadership
Bioptimus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boom Capital Ventures | Series A |
| Top Harvest Capital | Seed |
| HV Fund | Series A |
| NJF Capital | Seed |
| Andera Partners | Series A |
| Top Harvest Capital | Seed |
| Pomifer Capital Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 40% MoM, reaching 19K.
- Jul 20, 2026
Open roles increased to 63, 3.4x the trailing average.
Recent news
Latest coverage and updates
- is_developingSep 7, 2026
Bioptimus is developing AI foundation model.
- partners_withAug 20, 2026
Bioptimus partnered with Cancer Research Horizons on Aug 20th '26.
- launchesAug 16, 2026
Bioptimus launches supersized open-source AI model for disease research and diagnosis.
Bioptimus Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Bioptimus's valuation, stock price, and market status.
Is Bioptimus a public or private company?
Bioptimus is a private company.
What is the current stock price of Bioptimus?
Bioptimus is a private company with no public stock price. No recent secondary market data is available.
How much is Bioptimus worth (valuation)?
Valuation information for Bioptimus is not publicly available.
Can I buy Bioptimus stock?
Bioptimus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Bioptimus's last funding round?
Bioptimus's most recent funding round was Series A on January 14, 2025.
Who are the main investors in Bioptimus?
Key investors in Bioptimus include Sofinnova Partners, Bpifrance, Cathay Innovation.
Will Bioptimus IPO soon?
No public IPO plans have been announced for Bioptimus.
How can I track Bioptimus secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bioptimus's secondary market activity and sign up for updates.